Mark Schallenberger
Chief Operating Officer chez XTANT MEDICAL HOLDINGS, INC.
Fortune : 447 753 $ au 31/03/2024
Profil
Mark A.
Schallenberger is currently the Chief Operating Officer at Xtant Medical Holdings, Inc. and the Chief Operations Officer at Surgenex LLC.
Previously, he worked as the Senior Director of Marketing and Product Development at DCI Donor Services Tissue Bank from 2016 to 2019.
He holds a graduate degree from The Scripps Research Institute and an undergraduate degree from The University of Montana.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/04/2024 | 382 695 ( 0,29% ) | 447 753 $ | 31/03/2024 |
Postes actifs de Mark Schallenberger
| Sociétés | Poste | Début |
|---|---|---|
| XTANT MEDICAL HOLDINGS, INC. | Chief Operating Officer | 16/01/2023 |
| Surgenex LLC | Chief Operating Officer | 16/01/2023 |
Anciens postes connus de Mark Schallenberger
| Sociétés | Poste | Fin |
|---|---|---|
| DCI Donor Services Tissue Bank | Corporate Officer/Principal | 01/06/2019 |
Formation de Mark Schallenberger
| The Scripps Research Institute | Graduate Degree |
| The University of Montana | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| XTANT MEDICAL HOLDINGS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Surgenex LLC | |
| DCI Donor Services Tissue Bank |
